5 Diabetic Retinopathy Clinical Trials in Glendale, CA (2026)

Q: How do I join a clinical trial in Glendale?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Glendale research site will contact you.

Recruiting Diabetic Retinopathy Studies in Glendale

NCT07705555Recruiting

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-8748 can treat DME. An available standard (usual) tre...

Glendale, CAPHASE3960 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07734844Recruiting

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants with Diabetic Macular Edema - ALTO...

Glendale, CAPHASE3910 participantsKodiak Sciences Inc

View Study Details

NCT06321302Recruiting

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find ou...

Glendale, CAPHASE2175 participantsBoehringer Ingelheim

View Study Details

NCT07553429Recruiting

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

This study is open to adults with diabetic macular edema that involves the center of the eye. The purpose of this study is to find out how well different doses of a medicine called BI 3812465 are tole...

Glendale, CAPHASE149 participantsBoehringer Ingelheim

View Study Details

NCT07588100Recruiting

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy

This study will assess the safety, tolerability, and pharmacokinetics (PK) of intravitreal (IVT) injections of RO7663498 in participants with diabetic retinopathy (DR)....

Glendale, CAPHASE130 participantsHoffmann-La Roche

View Study Details

About Diabetic Retinopathy Clinical Trials in Glendale

Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.

There are currently 5 diabetic retinopathy clinical trials recruiting participants in Glendale, CA. These studies are seeking a combined 2,124 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Kodiak Sciences Inc, Boehringer Ingelheim and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Diabetic Retinopathy Clinical Trials in Glendale — FAQ

Are there diabetic retinopathy clinical trials in Glendale?

Yes, there are 5 diabetic retinopathy clinical trials currently recruiting in Glendale, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Glendale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Glendale research site will contact you about next steps.

Are clinical trials in Glendale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Glendale studies also compensate for your time and travel.

What diabetic retinopathy treatments are being tested?

The 5 active trials in Glendale are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.

Data updated October 16, 2026 from ClinicalTrials.gov